MDPediatrix Medical Group, Inc.
Is it safe?
Nothing alarming, nothing pristine: comfortable debt (A) and big price swings.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -91% · now at/near its 52-week high.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can MD take a bad year?
Pediatrix Medical Group, Inc. carries $180M of net debt at 0.76× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 0.76×
Net debt / EBITDA · 1.37× a year ago · the load is coming down
- Interest cover
- 6.31×
Interest cover · operating profit covers the interest bill several times over
- Annualised volatility
- 47%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $584M
- Cash and short-term investments
- $404M
- Net debt
- $180M
- EBITDA, trailing twelve months
- $239M
- Operating profit, trailing twelve months
- $215M
- Debt / equity
- 0.66×
- Total debt / EBITDA
- 2.45×
- Annualised volatilitytwo years of daily moves
- 47%
- Worst drawdown on file
- −91%
- Below its 52-week high
- 1.6%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.